Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1896
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands ; volume:17 ; number:6 ; day:23 ; month:8 ; year:2019 ; pages:857-873 ; date:12.2019
Applied health economics and health policy ; 17, Heft 6 (23.8.2019), 857-873, 12.2019
- Urheber
-
Michels, Renée Else
Fransesco, Maria de
Mahajan, Koshu
Hengstman, Gerald J. D.
Schiffers, Krijn M. H.
Budhia, Sangeeta
Harty, Gerard
Krol, Marieke
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40258-019-00500-8
- URN
-
urn:nbn:de:101:1-2020042920134968356037
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Michels, Renée Else
- Fransesco, Maria de
- Mahajan, Koshu
- Hengstman, Gerald J. D.
- Schiffers, Krijn M. H.
- Budhia, Sangeeta
- Harty, Gerard
- Krol, Marieke
- SpringerLink (Online service)
Ähnliche Objekte (12)
Relapsing/remitting type 1 diabetes
Cladribine Tablets for Relapsing–Remitting Multiple Sclerosis: A Clinician’s Review
Endocarditis following ocrelizumab in relapsing-remitting MS
Postural Control in Relapsing-Remitting Multiple Sclerosis
Correction to: Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands
Relapsing–remitting painful ophthalmoplegia due to orbital myositis
Abnormal multisensory integration in relapsing–remitting multiple sclerosis
Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing-remitting multiple sclerosis
Correlates and trajectories of relapses in relapsing–remitting multiple sclerosis
Relapsing/remitting type 1 diabetes
Cladribine Tablets for Relapsing–Remitting Multiple Sclerosis: A Clinician’s Review
Endocarditis following ocrelizumab in relapsing-remitting MS
Postural Control in Relapsing-Remitting Multiple Sclerosis
Correction to: Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands
Relapsing–remitting painful ophthalmoplegia due to orbital myositis
Abnormal multisensory integration in relapsing–remitting multiple sclerosis
Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing-remitting multiple sclerosis
Correlates and trajectories of relapses in relapsing–remitting multiple sclerosis
Relapsing/remitting type 1 diabetes
Cladribine Tablets for Relapsing–Remitting Multiple Sclerosis: A Clinician’s Review
Endocarditis following ocrelizumab in relapsing-remitting MS
Postural Control in Relapsing-Remitting Multiple Sclerosis
Correction to: Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands
Relapsing–remitting painful ophthalmoplegia due to orbital myositis
Abnormal multisensory integration in relapsing–remitting multiple sclerosis
Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing-remitting multiple sclerosis